P. Hanjani
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Quality of life and adverse events: prognostic relationships in long-term ovarian cancer survival
.
Journal of the National Cancer Institute.
2021
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
.
Annals of Oncology.
2017
Contact
full name
P.
Hanjani
Quick Info
Publications
Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science